[HTML][HTML] The neonatal Fc receptor (FcRn): a misnomer?

M Pyzik, KMK Sand, JJ Hubbard, JT Andersen… - Frontiers in …, 2019 - frontiersin.org
Antibodies are essential components of an adaptive immune response. Immunoglobulin G
(IgG) is the most common type of antibody found in circulation and extracellular fluids …

[HTML][HTML] Next-generation Fc receptor–targeting biologics for autoimmune diseases

AW Zuercher, R Spirig, AB Morelli, T Rowe… - Autoimmunity …, 2019 - Elsevier
In recent years, there has been a surge in the research and development of novel molecules
as potential therapeutic alternatives to traditional treatments (such as intravenous …

Engineered protein scaffolds as next-generation therapeutics

M Gebauer, A Skerra - Annual review of pharmacology and …, 2020 - annualreviews.org
The concept of engineering robust protein scaffolds for novel binding functions emerged 20
years ago, one decade after the advent of recombinant antibody technology. Early examples …

Bile acid transporter-mediated oral drug delivery

F Deng, YH Bae - Journal of Controlled Release, 2020 - Elsevier
Bile acids are synthesized in the liver, stored in the gallbladder, and secreted into the
duodenum at meals. Apical sodium-dependent bile acid transporter (ASBT), an ileal Na+ …

Targeting FcRn to generate antibody-based therapeutics

ES Ward, RJ Ober - Trends in pharmacological sciences, 2018 - cell.com
The MHC class I-related receptor FcRn serves multiple roles ranging from the regulation of
levels of IgG isotype antibodies and albumin throughout the body to the delivery of antigen …

[HTML][HTML] Neonatal Fc receptor–targeted therapies in neurology

C Nelke, M Spatola, CB Schroeter, H Wiendl… - …, 2022 - Elsevier
Autoantibodies are increasingly recognized for their pathogenic potential in a growing
number of neurological diseases. While myasthenia gravis represents the prototypic …

[HTML][HTML] Autoantibodies-enemies, and/or potential allies?

H Ma, C Murphy, CE Loscher… - Frontiers in Immunology, 2022 - frontiersin.org
Autoantibodies are well known as potentially highly harmful antibodies which attack the host
via binding to self-antigens, thus causing severe associated diseases and symptoms (eg …

[HTML][HTML] Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris

S Singh, A Barbarino, EG Youssef, D Coleman… - Journal of Fungi, 2023 - mdpi.com
Candida auris is a multi-drug-resistant fungal pathogen that can survive outside the host and
can easily spread and colonize the healthcare environment, medical devices, and human …

[HTML][HTML] In translation: FcRn across the therapeutic spectrum

T Qi, Y Cao - International Journal of Molecular Sciences, 2021 - mdpi.com
As an essential modulator of IgG disposition, the neonatal Fc receptor (FcRn) governs the
pharmacokinetics and functions many therapeutic modalities. In this review, we thoroughly …

[HTML][HTML] Emerging new approaches in desensitization: targeted therapies for HLA sensitization

AY Choi, M Manook, D Olaso, B Ezekian… - Frontiers in …, 2021 - frontiersin.org
There is an urgent need for therapeutic interventions for desensitization and antibody-
mediated rejection (AMR) in sensitized patients with preformed or de novo donor-specific …